BMJ  2004;328:102-103 (10 January), doi:10.1136/bmj.328.7431.102

Commentary

Supervised fixing rooms, supervised injectable maintenance clinics—understanding the difference

John Strang, director1, Rudi Fortson, barrister2

1 National Addiction Centre, King's College London, London SE5 8AF, 2 London WC1R 4HD

Correspondence to: J Strang johnstrang@iop.kcl.ac.uk

The first 150 words of the full text of this article appear below.

Harm reduction policies and practices (where anything goes, if it actually reduces harm) have fundamentally altered our approach to the drugs problem. Two innovations were recently considered by the Home Affairs Select Committee—supervised injecting centres and supervised injectable maintenance clinics—but with unhelpful confusion between the two.1 They have different target populations, potential benefits, and legal obstacles.

Supervised injecting centres (also known as supervised drug consumption rooms or fixing rooms) are essentially public access facilities, perhaps the injecting drug user's equivalent of a pub or bar, where the injection of unknown drugs by unknown persons should be safer by virtue of supervision and consequent speed of response in the event of overdose.2 The target population is all injecting drug misusers—regardless of whether or not they are dependent or wish to change their drug taking habits. Perhaps providing this safer haven may lead some to seek treatment. But this is not the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study
Thomas Kerr, Jo-Anne Stoltz, Mark Tyndall, Kathy Li, Ruth Zhang, Julio Montaner, and Evan Wood
BMJ 2006 332: 220-222. [Abstract] [Full Text] [PDF]

Supervised injecting centres
Nat M J Wright and Charlotte N E Tompkins
BMJ 2004 328: 100-102. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Kerr, T., Tyndall, M. W., Zhang, R., Lai, C., Montaner, J. S.G., Wood, E. (2007). Circumstances of First Injection Among Illicit Drug Users Accessing a Medically Supervised Safer Injection Facility. AJPH 97: 1228-1230 [Abstract] [Full text]  
  • Wood, E., Tyndall, M. W., Montaner, J. S., Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.. CMAJ 175: 1399-1404 [Abstract] [Full text]  
  • Kerr, T., Stoltz, J.-A., Tyndall, M., Li, K., Zhang, R., Montaner, J., Wood, E. (2006). Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ 332: 220-222 [Abstract] [Full text]  
  • Mills, K. (2004). Reducing drug-related deaths: The responsibility of NOMS?. Probation Journal 51: 407-414 [Abstract]  

Rapid Responses:

Read all Rapid Responses

Medically Supervised Injecting Rooms Work
Dr Raymond C Seidler
bmj.com, 14 Jan 2004 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ